News & Resources
Read our latest insights and explore our resources, including company updates, articles, white papers, case studies, webinars and more.
-
PCM Trials, EmVenio Research, and Clinical Trial Service Rebrand as EmVenio Clinical Research
EmVenio Clinical Research expands global trial access with brand consolidation and launches Patient Navigator to improve access for trial participants. DENVER, Colo., Aug. 25, 2025 – PCM Trials, along with its subsidiaries EmVenio Research and Clinical Trial Service, are aligning under a single name – EmVenio Clinical Research. This consolidation […]
-
Now introducing: EmVenio Clinical Research
Welcome to EmVenio Clinical Research – the next era of PCM Trials, EmVenio Research and Clinical Trial Service. Our new visual identity is now authentically us: warm, welcoming, and human-centered. We’re excited to introduce our new brand – and share the journey that brought us here. How did we get […]
-
EmVenio Puts the Reach in Research
EmVenio is a global leader in clinical research, committed to helping researchers make medical breakthroughs. Delivering consistent results and making research available for all starts with meeting patients where they are—in their homes, in their communities, or where they gather. Through our mobile teams, virtual visits, and local research sites, […]
-
Community research case study: How EmVenio streamlined enrollment of diverse and highly qualified patients in a metabolic disease trial
EmVenio’s Community Research Sites are embedded in communities that yield patients of diverse backgrounds with limited access to clinical research options. Download this case study to learn how the company established two new Community Research Sites dedicated for a sponsor’s weight loss study, including key stats supporting the trial’s success […]
-
Bridging gaps in neurology trials: How community-based research models expand access
As momentum continues to grow in neurology research, how can community-based research models help overcome recruitment and retention challenges in complex areas like Alzheimer’s? According to data published in a landmark study tracking the global burden of diseases, more than 3 billion people worldwide are living with a neurological condition […]
-
Addressing patient barriers to clinical trial participation
Clinical trials are essential for advancing medical research and developing new treatments. Gathering accurate and comprehensive data from these trials is crucial for ensuring the safety and efficacy of new therapies. However, the journey for patients who enroll in these trials often involves significant time commitments and various activities that […]
-
Infectious diseases and community research: How to improve reach and results
Embracing alternative, patient-centric ways of clinical trial delivery could be critical to expanding reach and enhancing data collection in infectious disease trials. Global immunization programs have successfully eradicated or controlled many infectious diseases throughout history. However, challenges like antimicrobial resistance, climate change, and the potential threat of biological warfare are […]
-
EmVenio team attends 2025 World Vaccine Congress
This April, the EmVenio and PCM Trials team traveled to Washington, D.C., for the 2025 World Vaccine Congress. In addition to attending informative panels, lectures and sessions on everything from research to commercial manufacturing of vaccines, our team hosted a variety of events to engage with those in attendance. Thad […]
-
PCM Trials: Bridging Research and Real Lives: How Marci Kay Livingston is Advancing Patient-Centric Care as a CMRN
Meet Marci Kay Livingston, a Certified Mobile Research Nurse (CMRN) at PCM Trials. Mobile clinicians play a vital role in supporting participant optionality by bringing clinical trials directly to patients, wherever they are. With a background in emergency, hospice, and palliative care, Marci brings deep compassion and adaptability to every patient encounter. […]
-
EmVenio Research wins Best Clinical Trial Company award at 2025 ViE Awards
DENVER, Colo., May 12, 2025 – Clinical trials organization EmVenio Research was named winner for Best Clinical Trial Company at the 2025 Vaccine Industry Excellence Awards. The award ceremony was held April 22 during the 2025 World Vaccine Congress in Washington, D.C. The award recognizes companies that excel in meeting clinical development needs through […]
-
How FDA’s Guidance on Decentralized Trials Applies to Community-based Research Execution and Compliance
In September 2024, the U.S. Food and Drug Administration (FDA) issued its final guidance titled Conducting Clinical Trials with Decentralized Elements. The document outlines how decentralized trial components—particularly mobile visits conducted in participants’ homes, mobile research sites, and local community health facilities—can be implemented in a compliant, regulated framework. The guidance […]
-
Virtually tour our dedicated research sites within Prime Healthcare
In the summer of 2024, EmVenio launched brick-and-mortar clinical trial research centers on select Prime hospital campuses. Like our mobile community research sites, these locations were strategically chosen using social determinants of health of the surrounding community. The sites reach new patient demographics that are statistically underrepresented in clinical trials, […]
